Modulation of Immune Response via Tissue Factor CD142

Kurzbeschreibung:
The invention will help to modulate the immune response in patients in whom the systemic immune response is compromised through a novel pathway.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de